Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onconova hammered after top drug rigosertib flunks key PhIII study
Onconova hammered after top drug rigosertib flunks key PhIII study
Onconova hammered after top drug rigosertib flunks key PhIII study
Submitted by
admin
on February 20, 2014 - 5:33pm
Source:
Fierce Biotech
News Tags:
Onconova
Rigosertib
myelodysplastic syndromes
Headline:
Onconova hammered after top drug rigosertib flunks key PhIII study
Do Not Allow Advertisers to Use My Personal information
